We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Aim Immunotech Inc | LSE:0A4Y | London | Ordinary Share | AIM IMMUNOTECH ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 2,475 | - |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 202k | -28.96M | -0.5930 | -3.04 | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/9/2024 | 13:00 | UKREG | AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of.. |
| 09/5/2024 | 13:50 | UKREG | AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16,.. |
| 06/5/2024 | 13:30 | UKREG | AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® |
| 29/4/2024 | 13:55 | UKREG | AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in.. |
| 10/4/2024 | 13:21 | UKREG | AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report.. |
| 02/4/2024 | 12:30 | UKREG | AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results.. |
| 26/3/2024 | 13:05 | UKREG | AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial.. |
| 25/3/2024 | 13:05 | UKREG | AIM ImmunoTech Announces Publication of Positive Findings from a Study.. |
| 07/3/2024 | 13:45 | UKREG | AIM ImmunoTech Announces Launch of CEO Corner Platform |
| 29/2/2024 | 13:45 | UKREG | AIM ImmunoTech Outlines Recent Progress Across Clinical Development.. |
1 Year Aim Immunotech Chart |
Intraday Aim Immunotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
